CR20110473A - VARIATIONS OF UNION TO ANTI-ALBÚMINA DE SERERO IMPROVED. - Google Patents

VARIATIONS OF UNION TO ANTI-ALBÚMINA DE SERERO IMPROVED.

Info

Publication number
CR20110473A
CR20110473A CR20110473A CR20110473A CR20110473A CR 20110473 A CR20110473 A CR 20110473A CR 20110473 A CR20110473 A CR 20110473A CR 20110473 A CR20110473 A CR 20110473A CR 20110473 A CR20110473 A CR 20110473A
Authority
CR
Costa Rica
Prior art keywords
improved
albúmina
serero
union
variations
Prior art date
Application number
CR20110473A
Other languages
Spanish (es)
Inventor
Angelis Elena De
Carolyn Enever
Haiqun Liu
Oliver Schon
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to CR20110473A priority Critical patent/CR20110473A/en
Publication of CR20110473A publication Critical patent/CR20110473A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

La invención se refiere a variantes mejoradas del dominio variable sencillo de inmunoglobulina anti-albúmina de suero DOM7h-14, así como a ligandos y conjugados de fármacos que comprenden dichas variantes, composiciones, ácido nucleicos, vectores y huéspedesThe invention relates to improved variants of the single variable domain of serum anti-albumin immunoglobulin DOM7h-14, as well as ligands and conjugates of drugs comprising said variants, compositions, nucleic acids, vectors and hosts

CR20110473A 2011-09-02 2011-09-02 VARIATIONS OF UNION TO ANTI-ALBÚMINA DE SERERO IMPROVED. CR20110473A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR20110473A CR20110473A (en) 2011-09-02 2011-09-02 VARIATIONS OF UNION TO ANTI-ALBÚMINA DE SERERO IMPROVED.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR20110473A CR20110473A (en) 2011-09-02 2011-09-02 VARIATIONS OF UNION TO ANTI-ALBÚMINA DE SERERO IMPROVED.

Publications (1)

Publication Number Publication Date
CR20110473A true CR20110473A (en) 2011-10-04

Family

ID=44999613

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20110473A CR20110473A (en) 2011-09-02 2011-09-02 VARIATIONS OF UNION TO ANTI-ALBÚMINA DE SERERO IMPROVED.

Country Status (1)

Country Link
CR (1) CR20110473A (en)

Similar Documents

Publication Publication Date Title
DOP2011000269A (en) VARIATIONS OF UNION TO ANTI-ALBUMINA OF SUERO IMPROVED
CO6410311A2 (en) VARIATIONS OF UNION TO ANTI-ALBÚMINA DE SERERO IMPROVED
CY1121349T1 (en) PYROLOVENZODIAZEPINE ANTIBODIES CONJECTIONS
CY1120916T1 (en) PYROLOVENZODIAZEPINE-ANTIBODY CONJECTIONS AGAINST PSMA
CY1120327T1 (en) ANTIBODY-PYRROLOVENZODIAZEPINIS CONDENSERS
CY1121862T1 (en) ANTI-PHF-TAU ANTIBODIES AND USES THEREOF
CY1119782T1 (en) PYRROLOVENZODIAZEPIN-ANTI-COMPONENT ANTI-CD22 CONNECTIONS
CY1119287T1 (en) PYRROLOVENZODIAZEPIN-ANTI-ANTIBODIES ANTIBODIES
EA201401254A1 (en) САМОСТАБИЛИЗИРУСЩИЕСЯ ЛИНКЕРНЫЕ КОНЪЮГАТЫ
EA201992456A3 (en) SELF-STABILIZING LINKER CONJUGATES
IN2012DN00640A (en)
EA201291009A1 (en) IMPROVED CONNECTING OPTIONS AGAINST SERUM ALBUMIN
WO2014160160A3 (en) Antibody drug conjugates and corresponding antibodies
TR201911139T4 (en) Cytotoxic and anti-mitotic compounds and methods of using them.
EA201390785A1 (en) ANTIBODIES THAT HAVE LOW AFFINITY TO HEMATOEPHALIC BARRIER RECEPTORS AND THEIR APPLICATIONS
EA201590173A1 (en) IMMUNOCONGUTS CONTAINING ANTIBODIES TO CD22
EA201171325A1 (en) NUCLEIC ACIDS CONNECTING WITH HEPSIDIN
UY34582A (en) ANTI-CXCR3 ANTIBODIES
TR201905787T4 (en) Lyophilized TAT-NR2B9C formulation.
GB2495884A (en) A method of increasing the effect of an activated-potentiated form of an antibody
EA201390116A1 (en) IMPROVED CONNECTING OPTIONS AGAINST SERUM ALBUMIN
WO2014044793A3 (en) Cd22-binding peptides
BR112013032223A2 (en) isolated nucleic acid molecule and composition
CR20110473A (en) VARIATIONS OF UNION TO ANTI-ALBÚMINA DE SERERO IMPROVED.
MY171206A (en) A method of increasing the effect of an activated-potentiated form of an antibody